Pharmacy Times
AUGUST 17, 2023
The findings of the study demonstrate the need for preventive interventions for all infants in order to reduce the burden of severe illness from respiratory syncytial virus lower respiratory tract infections.
Drug Topics
AUGUST 17, 2023
Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 17, 2023
The Mylight phase 3 trial confirmed that there was no clinically meaningful differences between aflibercept and its reference biologic, Eylea, for patients with wet macular degeneration.
Drug Topics
AUGUST 17, 2023
Appeals court puts restrictions on access to mifepristone, Blue Shield of California drops CVS Health, and Americans think opioids and obesity are the 2 biggest threats to public health.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 17, 2023
Adjustments for social determinants of health in the US population had a significant impact on cardiovascular disease mortality data between Black and White populations.
Drug Topics
AUGUST 17, 2023
Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
ISPE
AUGUST 17, 2023
2022 Roger F. Sherwood Article of the Year Award Finalists Announced Trudy Patterson Thu, 08/17/2023 - 11:22 iSpeak Blog iSpeak 2022 Roger F. Sherwood Article of the Year Award Finalists Announced ISPE 17 August 2023 Pharmaceutical Engineering ® is delighted to announce the finalists for the 2022 Roger F. Sherwood Article of the Year Award. The articles were selected by judges of 36 feature and technical articles published in Pharmaceutical Engineering during the 2022 calendar year (Volume 42).
Pharmacy Times
AUGUST 17, 2023
A COVID-19 booster dose increased both maternal and cord blood binding and neutralizing antibody levels against virus strains, including Omicron BA.1.
STAT
AUGUST 17, 2023
When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.
Fierce Healthcare
AUGUST 17, 2023
David Entwistle has a storied career as a healthcare executive leading new innovations and steering strategic growth at academic medical centers. | Stanford Health Care CEO David Entwistle joined the board of directors at New York City-based Redesign Health. Here are the areas of healthcare he thinks are ripe for innovation.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 17, 2023
The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates. It also provided a stable stream of wealth for top executives, who collectively pocketed billions of dollars in what was otherwise a rough patch for the economy. By almost every measure, 2022 was a bad year for the stock market.
Fierce Healthcare
AUGUST 17, 2023
Blue Shield of California today unveiled a new model for pharmacy care that it hopes will overhaul the “broken prescr | Blue Shield of California hopes to cut prescription drugs costs between 10% and 15%, or about $500 million a year, with an ambitious program that sidesteps the pharmacy benefit manager.
STAT
AUGUST 17, 2023
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du
Fierce Healthcare
AUGUST 17, 2023
A recent survey from eHealth, an independent Medicare insurance adviser, released new data that shows 84% of respondents believe Medicare needs reform, but just 12% think changes should impact thei | A new survey shows that while seniors acknowledge Medicare reform is critical to the program's future, they expect to receive benefits at the cost they were promised.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
AUGUST 17, 2023
Despite all the upheaval in the pharma industry over the last few years, many familiar names will remain at the top of the industry's sales charts toward the end of the decade. | Merck cancer superstar Keytruda is projected to be the world’s top selling drug by a huge margin in 2028, according to a report by Evaluate. On its list of top 10 drugs by sales in 2028, Keytruda is expected to top the $30 billion mark, with no other therapy predicted to reach $20 billion in sales.
Fierce Healthcare
AUGUST 17, 2023
Healthcare Outcomes Performance Company, a national leader in musculoskeletal practice and clinical outcomes management solutions, has partnered with Provider Network Solutions to establish a joint | Under a new joint venture with Provider Network Solutions (PNS) in Florida, HOPCo Network Solutions will add 1,100 new orthopedic, pain management and podiatry partners.
Fierce Pharma
AUGUST 17, 2023
As GSK’s ViiV Healthcare looks to widen the reach of its HIV franchise, Médecins Sans Frontières (MSF) has been working to secure access to the company's long-acting HIV prevention drug, Apretude, | The advocacy organization has been trying to lock down supplies of ViiV's long-acting Apretude for more than a year. Now, it's asking the HIV-focused company to remove recently added clauses in the contract that it says derail transparency.
Fierce Healthcare
AUGUST 17, 2023
Mayo Clinic built on its solid first quarter with an even stronger $300 million fro | The nonprofit's six-month revenues are up 9.8% year over year, outpacing an 8.2% rise in expenses. For the second quarter, management attributed its nearly $4.5 billion total revenue to “overperformance in core operations as well as positive investment returns.
Fierce Pharma
AUGUST 17, 2023
Nine states are saying not so fast to a proposed $13.5 million settlement that would get Eli Lilly out of hot water over claims it jacked up the price of its lucrative insulin product Humalog. | In a Tuesday filing in New Jersey Federal Court, lawyers for several states urged U.S. District Judge Brian Martinotti to delay the approval of Lilly's proposed $13.5 million settlement unless it’s altered to make sure states can still file their own insulin pricing lawsuits.
Fierce Healthcare
AUGUST 17, 2023
Amid warnings that emergency departments are not fully equipped to meet rising mental and behavioral health (MBH) needs of minors, a trio of healthcare professional organizations is calling for mor | Recent years have cemented emergency departments as critical access points and safety net care providers for kids with mental and behavioral health conditions.
Fierce Pharma
AUGUST 17, 2023
As companies have flocked to compete in the new respiratory syncytial virus (RSV) vaccine market, GSK has had the best timing. | As companies have flocked to compete in the new respiratory syncytial virus (RSV) vaccine market, GSK has had the best timing. In May, the U.K. company was first to secure FDA approval for its shot Arexvy for adults 60 and older, beating out rivals from Pfizer and Moderna.
Fierce Healthcare
AUGUST 17, 2023
Pocket Health, a medical image-sharing platform, has launched a tool to help patients stay on top of their follow-up recommendations. | Whether the instructions are to schedule another appointment, tissue sampling or lab work, Follow-Up Navigator will surface them to the patient and prompt them to take action.
STAT
AUGUST 17, 2023
A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers, dealing a setback to efforts to curtail the dominant role these controversial middlemen play in the pharmaceutical supply chain. The Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers that sued to block the law, objected to Oklahoma’s attempt to “interfere” with efforts to administer health plans tha
Hospital Pharmacy Europe
AUGUST 17, 2023
Guidance on the provision of CAR T and cellular therapy services in hospital pharmacy has been published by the GoCART Coalition to harmonise implementation across Europe. Here, Tiene Bauters PharmD PhD, Pharmacy, Department of Pediatric Hemato-Oncology & Stem Cell Transplantation at Ghent University Hospital in Belgium, shares an overview of the involvement of the pharmacist in CAR T-cell services.
Fierce Pharma
AUGUST 17, 2023
In the aftermath of devastating wildfires on Maui, Bayer is standing up as one of the first pharmaceutical companies to offer relief. | Bayer is providing a cash donation of $250,000 to Maui, plus a donation of essential healthcare products also worth $250,000. Bayer has operated in Maui for more than half a century, the company said Wednesday. The Hawaiian island has been devastated by wildfires this month.
Drug Store News
AUGUST 17, 2023
The virtual event, held on Oct. 11-13, seeks suppliers with sustainable products in the food, health and beauty, everyday essentials, pet, apparel and general merchandise categories.
ISPE
AUGUST 17, 2023
Establishing Data Governance within the Digital Validation Sector Logan Thomas Thu, 08/17/2023 - 12:30 iSpeak Blog iSpeak Establishing Data Governance within the Digital Validation Sector Dave O’Connor Pierre J E Winnepenninckx Gerard Carton George Brunner 17 August 2023 Data Governance is currently utilized in many areas of business and government including finance, banking, telecommunications, and by the agencies regulating these industries.
Hospital Pharmacy Europe
AUGUST 17, 2023
A treatment combining cipaglucosidase alfa (Pombiliti) and miglustat (Opfolda) for adults living with late-onset Pompe disease has been granted marketing authorisation by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Cipaglucosidase alfa is a long-term enzyme replacement therapy (ERT) used in combination with the enzyme stabiliser miglustat for adults with late-onset Pompe disease.
STAT
AUGUST 17, 2023
Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like Alzheimer’s disease, cancer, and heart disease that affect the lives of so many Americans. For many patients, the first step will be genetic testing and counseling by a board-certified genetic counselor.
Fierce Pharma
AUGUST 17, 2023
Johnson & Johnson and Legend Biotech's Carvykti keeps growing despite a newly launched off-the-shelf option. | J&J and Legend Biotech's Carvykti kept growing despite a newly launched off-the-shelf option. Novo Holdings joined a $290 million investment in a Chinese R&D product and service provider. China is stressing biotech as a “major focus” as the country tries to woo foreign investment.
STAT
AUGUST 17, 2023
What difference does a day make? Who gets to have gene therapy? And are biotech startups OK? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays.
Fierce Healthcare
AUGUST 17, 2023
Select Health is teaming up with grocer Kroger to launch new co-branded Medicare Advantage (MA) plans that aim to improve access to healthy food and affordable medications. | The new plans will first be offered in select counties across four states Select Health, a subsidiary of Intermountain Healthcare, serves: Colorado, Idaho, Utah and Nevada.
STAT
AUGUST 17, 2023
There are people in your life who influence and shape how you see the world. For me, one of these people is Terry Moakley, a warm and welcoming family friend, a veteran of the Vietnam War, and a fervent advocate for people with disabilities. After he became a quadriplegic as a result of an injury, he began a decades-long career dedicated to improving disability access.
Fierce Healthcare
AUGUST 17, 2023
As one of a small group of people working to develop and deploy COVID-19 testing at the very start of the pandemic, I witnessed both major blunders and genius breakthroughs, but what sticks with me | There are lessons we learned during the COVID-19 response that can and should inform our response to today’s record levels of depression, anxiety and other mental health conditions.
Expert insights. Personalized for you.
123 
Let's personalize your content